With COVID-19 intensifying again, Pfizer is raising its sales estimate for 2021 by 28.8% - to $ 33.5 billion.
The company's forecast is based on deals it signed this year for the sale of 2.1 billion vaccine doses.
With COVID-19 intensifying again, Pfizer is raising its sales estimate for 2021 by 28.8% - to $ 33.5 billion.
The company's forecast is based on deals it signed this year for the sale of 2.1 billion vaccine doses.